Baker Brothers Bets Big on DBV: Pre‑Funded Warrants Could Shake Up Shares Ahead of Next Clinical Milestone
Insider moves reveal a strategic shift at DBV as Baker Brothers Advisors LP converts warrants into low‑strike pre‑funded instruments, betting on future growth while exposing investors to potential dilution tied to upcoming clinical milestones.
3 minutes to read